ICO
Closed:

Orally Bioavailable Peptides and/or Peptide Therapeutics for Modulating Intracellular Targets

A top five pharmaceutical company with a history of successful academic collaborations, wishes to identify novel methods that allow for the discovery or design of orally bioavailable peptides and/or peptides that can access intracellular targets through passive permeation, endocytosis or via transporters.

Approaches of Interest

  • Peptides designed to be intrinsically permeable/orally bioavailable through rational design (e.g., cyclisation, incorporation of non-natural amino acids, etc), next generation conjugation or other innovative approaches
  • Design of ...

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.